- Home
- News & Events
- In the News
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
How digital is reversing fortunes in R&D
A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.
Tom O’Leary, ICON, Chief Information Officer at ICON outlines a number of factors behind the decline in return on investment (ROI) in this Pharmaphorum article.
-
Best Practices in Seasonal Vaccine Efficacy Studies: Tips for Successful Planning and Execution
A thought leadership piece by Cindy Dukes exploring the unique challenges in planning and executing a seasonal vaccine study.
-
Is Pharma Finally Heading for Launch Excellence?
The traditional approaches to launching a new medicine still tend to sit in the commercial function, but they need to better align with HEOR, medical affairs and clinical teams. Read more in the February issue of PME.
-
-
Rethinking Patient and Site Engagement
A thought leadership article by Dr. Nuala Murphy, President Clinical Research Services, exploring how protocol optimisation can be instrumental in improving patient and site engagement to mobilise increasingly complex clinical trials.
-
Decentralized and Hybrid Trials
An article by Gretchen Goller and Kristin Kinlaw which outlines patient feedback from a recent survey regarding the use of decentralized and hybrid trials in the pharmaceutical industry.
-
Keeping it Real: Challenges and Benefits of Integrating AI and Machine Learning into Pharma R&D
ICON's CIO Tom O'Leary provides expert commentary on integrating AI and machine learning into Pharma R&D in this January 2020 Bio IT World Article.
-
Driving Clinical Trials Forward: The Benefits of Establishing a Strategic Partnership for Flow Cytometry
A thought leadership article authored by multiple contributors from ICON’s R&D department, which focuses on the future of Flow Cytometry as a sophisticated technology.
-
The life sciences industry in Ireland
Read The Irish Times’ article featuring commentary from ICON’s Dr. Nuala Murphy on career development and workforce talent in the Life Sciences industry in Ireland.
-
A Special Report on Liver Disease: The Phantom Menace
ICON's Martin Benson provides expert commentary on liver disease in this December 2019 DDN News article.